These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 24629410)
1. Hemoglobin A1c predicts heart failure hospitalization independent of baseline cardiac function or B-type natriuretic peptide level. Kishimoto I; Makino H; Ohata Y; Tamanaha T; Tochiya M; Kada A; Ishihara M; Anzai T; Shimizu W; Yasuda S; Ogawa H Diabetes Res Clin Pract; 2014 May; 104(2):257-65. PubMed ID: 24629410 [TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Get With the Guidelines-Heart Failure Risk Score in Patients With Chronic Heart Failure After Hospitalization. Suzuki S; Yoshihisa A; Sato Y; Kanno Y; Watanabe S; Abe S; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Ishida T; Takeishi Y J Am Heart Assoc; 2018 Sep; 7(17):e008316. PubMed ID: 30371158 [TBL] [Abstract][Full Text] [Related]
3. Higher hemoglobin A1c levels are associated with impaired left ventricular diastolic function and higher incidence of adverse cardiac events in patients with nonischemic dilated cardiomyopathy. Ikeda Y; Inomata T; Fujita T; Iida Y; Kaida T; Nabeta T; Ishii S; Maekawa E; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Ako J Heart Vessels; 2017 Apr; 32(4):446-457. PubMed ID: 27672077 [TBL] [Abstract][Full Text] [Related]
4. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome. Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645 [TBL] [Abstract][Full Text] [Related]
5. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction. Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958 [TBL] [Abstract][Full Text] [Related]
6. Increased perioperative b-type natriuretic peptide associates with heart failure hospitalization or heart failure death after coronary artery bypass graft surgery. Fox AA; Nascimben L; Body SC; Collard CD; Mitani AA; Liu KY; Muehlschlegel JD; Shernan SK; Marcantonio ER Anesthesiology; 2013 Aug; 119(2):284-94. PubMed ID: 23695172 [TBL] [Abstract][Full Text] [Related]
7. The impact of an inverse correlation between plasma B-type natriuretic peptide levels and insulin resistance on the diabetic condition in patients with heart failure. Inoue Y; Kawai M; Minai K; Ogawa K; Nagoshi T; Ogawa T; Yoshimura M Metabolism; 2016 Mar; 65(3):38-47. PubMed ID: 26892514 [TBL] [Abstract][Full Text] [Related]
8. Association of hemoglobin A1c variability and the incidence of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and arterial hypertension. Gu J; Fan YQ; Zhang JF; Wang CQ Hellenic J Cardiol; 2018; 59(2):91-97. PubMed ID: 28818638 [TBL] [Abstract][Full Text] [Related]
9. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction. Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760 [TBL] [Abstract][Full Text] [Related]
10. Pedal Edema as an Indicator of Early Heart Failure in the Community: Prevalence and Associations With Cardiac Structure/Function and Natriuretic Peptides (MESA [Multiethnic Study of Atherosclerosis]). Yeboah J; Bertoni A; Qureshi W; Aggarwal S; Lima JA; Kawel-Boehm N; Bluemke DA; Shah SJ Circ Heart Fail; 2016 Dec; 9(12):. PubMed ID: 27923806 [TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus. Gu J; Pan JA; Fan YQ; Zhang HL; Zhang JF; Wang CQ Cardiovasc Diabetol; 2018 Jun; 17(1):96. PubMed ID: 29960591 [TBL] [Abstract][Full Text] [Related]
12. Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial. Kristensen SL; Preiss D; Jhund PS; Squire I; Cardoso JS; Merkely B; Martinez F; Starling RC; Desai AS; Lefkowitz MP; Rizkala AR; Rouleau JL; Shi VC; Solomon SD; Swedberg K; Zile MR; McMurray JJ; Packer M; Circ Heart Fail; 2016 Jan; 9(1):. PubMed ID: 26754626 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy. Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307 [TBL] [Abstract][Full Text] [Related]
14. HbA1c and heart failure risk among diabetic patients. Zhao W; Katzmarzyk PT; Horswell R; Wang Y; Johnson J; Hu G J Clin Endocrinol Metab; 2014 Feb; 99(2):E263-7. PubMed ID: 24297797 [TBL] [Abstract][Full Text] [Related]
15. Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial. Segar MW; Patel KV; Vaduganathan M; Caughey MC; Butler J; Fonarow GC; Grodin JL; McGuire DK; Pandey A Diabetes Care; 2020 Aug; 43(8):1920-1928. PubMed ID: 32540922 [TBL] [Abstract][Full Text] [Related]
16. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors. Suzuki S; Sugiyama S Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934 [TBL] [Abstract][Full Text] [Related]
17. Slightly elevated B-type natriuretic peptide levels in a non-heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn Study. van den Hurk K; Alssema M; Kamp O; Henry RM; Stehouwer CD; Diamant M; Boomsma F; Heine RJ; Nijpels G; Paulus WJ; Dekker JM Eur J Heart Fail; 2010 Sep; 12(9):958-65. PubMed ID: 20667891 [TBL] [Abstract][Full Text] [Related]
18. Glycemic control and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: insight from ventricular remodeling using cardiac MRI. Shi K; Zhang G; Fu H; Li XM; Gao Y; Shi R; Xu HY; Li Y; Guo YK; Yang ZG Cardiovasc Diabetol; 2024 Apr; 23(1):148. PubMed ID: 38685007 [TBL] [Abstract][Full Text] [Related]
19. Long-Term Prognostic Significance of Plasma B-Type Natriuretic Peptide Level in Patients With Acute Heart Failure With Reduced, Mid-Range, and Preserved Ejection Fractions. Hamatani Y; Nagai T; Shiraishi Y; Kohsaka S; Nakai M; Nishimura K; Kohno T; Nagatomo Y; Asaumi Y; Goda A; Mizuno A; Yasuda S; Ogawa H; Yoshikawa T; Anzai T; Am J Cardiol; 2018 Mar; 121(6):731-738. PubMed ID: 29394996 [TBL] [Abstract][Full Text] [Related]
20. Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study. Jhund PS; Anand IS; Komajda M; Claggett BL; McKelvie RS; Zile MR; Carson PE; McMurray JJ Eur J Heart Fail; 2015 Aug; 17(8):809-17. PubMed ID: 25921853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]